ABHD5 and prostate cancer: By overexpressing ABHD5 in the lung cancer cell line H1299, we observed that ABHD5 significantly reduces the ability of these cells to synthesize nascent proteins (Fig. S4), which provides initial evidence that ABHD5 suppresses the cellular anabolism of another cancer type in addition to the prostate cancer cells.